About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Social Cognitive Training for Psychosis: Treatment Development

NCT01579422·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Yale University

With

National Institute of Mental Health (NIMH)

Age

18–55

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of schizophrenia or other psychotic disorder
Age between 18 and 55
Psychiatrically stable
Clinician agrees to individual's participation in study
English as primary language

You may not be if

current (past 30 days) symptoms of alcohol abuse/dependence
developmental disability
severe auditory/visual impairment or known neurological disorder
participant has a legal conservator

The record

StatusCompleted

PhasePhase 1

Taking part77

StartedMay 2012

UpdatedJan 12, 2016

Conditions

Schizophrenia Psychosis

Where1

VA Connecticut Healthcare System
West Haven, Connecticut, United States

Clareo Health | Social Cognitive Training for Psychosis: Treatment Development